Insurance policies in the United States may explain part of the outcome differences of adolescents and young adults with acute lymphoblastic leukemia treated on adult versus pediatric regimens.
Kantarjian
Hagop M
HM
O'Brien
Susan
S
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols; D006801:Humans; D007341:Insurance; D017063:Outcome Assessment, Health Care; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000191:economics*; D055815:Young Adult